Breast Cancer Risk Reduction Panel - Disclosures
Panel Member
|
Banu Arun MD |
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP |
Date Completed
|
04/20/2025 |
Panel Member
|
Mary Anne Bergman |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Therese Bevers MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Roma Bhatia MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Graham Colditz MD, DrPH, FAFPHM |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sarah DeVincenzo PharmD, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Laura Fejerman PhD, MSc |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Carla Fisher MD, MBA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Heidi Goodwin APRN, CNP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
William Gradishar MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kathleen Henderson MSN, ANP-BC |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ashley Hendrix MD, MBA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Shelley Hwang MD, MPH |
Equity Interest/Stock Options
|
| exai bio |
Date Completed
|
06/07/2024 |
Panel Member
|
Lisa Jacobs MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Judith Jordan BS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tari King MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rashmi Kumar PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Allison Kurian MD, MSc |
Grant/Research Support
|
| Myriad Genetic Laboratories, Inc. |
Date Completed
|
07/29/2024 |
Panel Member
|
Loretta Loftus MD, MBA |
Equity Interest/Stock Options
|
| AbbVie, Inc. | Amgen Inc. | Eli Lilly and Company | Gilead Sciences, Inc. | Johnson & Johnson | Pfizer Inc. |
Date Completed
|
05/08/2025 |
Panel Member
|
Aashini Master DO |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sofia Merajver MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ingrid Meszoely MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Tracy-Ann Moo MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rita Mukhtar MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Catherine Parker MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ellie Proussaloglou MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Asal Rahimi MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sagar Sardesai MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Victoria Seewaldt MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Payal Shah MD |
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP | Daiichi- Sankyo Co. | Gilead Sciences, Inc. |
Date Completed
|
03/14/2025 |
Panel Member
|
Sarah Shubeck MD, MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Michelle Specht MD, FACS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Anne Wallace MD, FACS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lee Wilke MD, FACS |
Equity Interest/Stock Options
|
| Elucent Medical |
Grant/Research Support
|
| Perimeter Medical |
Date Completed
|
06/23/2024 |
Panel Member
|
Amulya Yellala MBBS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rachel Yung MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |